INVO Bioscience, Inc. 8-K Summary
Business Context and Reporting Period
INVO Bioscience, Inc. (formerly INVO Fertility, Inc.) filed this Form 8-K on August 16, 2021. The filing serves to announce the company's financial results for the period ended June 30, 2021. The company is incorporated in Nevada and trades on The Nasdaq Stock Market LLC under the symbol "INVO."
Financial Metrics
This 8-K filing acts as a notification of a press release and does not contain specific financial data within its text. The filing states that the detailed results for revenue, profit, cash flow, margins, debt, and liquidity are contained in the press release furnished as Exhibit 99.1. Consequently, this document does not provide clear values for any specific financial metrics.
Material Changes
The filing does not detail specific material changes versus prior periods. It references the press release (Exhibit 99.1) for the announcement of results for the period ended June 30, 2021, but does not summarize the variances or trends in this text.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It further notes that this information shall not be incorporated by reference into any other Company filing unless expressly incorporated. No specific guidance, outlook, or risk factors are detailed in the body of this 8-K.
Key Facts for Investor Verification
- Verify the specific financial figures (revenue, net loss, cash position) in the press release attached as Exhibit 99.1, as they are not listed in this 8-K text.
- Confirm the company's name change from INVO Fertility, Inc. to INVO Bioscience, Inc. as reflected in the registrant header.
- Note that the financial data in the referenced press release is not legally "filed" under the Exchange Act and is not incorporated by reference into future filings.
- Review the full text of Exhibit 99.1 for any management commentary or forward-looking statements regarding the June 30, 2021 period.